Join us on the UC Berkeley campus on Tuesday, April 14, at 2 p.m. PDT for a seminar and fireside chat with one of the Forum’s most prominent members, Dr. Rebecca Taub. She is the Founder, Director, and SeniorMedical and Scientific Advisor at Madrigal Pharmaceuticals, as well as the Industry Co-Chair of the Liver Forum Steering Committee. The seminar will explore the development and approval journey for new drugs, particularly Madrigal's Rezdiffra (resmetirom), the first disease-specific treatment for metabolic dysfunction-associatedsteatohepatitis (MASH).

For more information on the seminar, visit forumresearch.formstack.com/forms/forum_april.